Sanna Rosengren

Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist

Hal M. Hoffman, Sanna Rosengren, David L. Boyle et al. · The Lancet · 2004 · 551 citations

Medicine, Immunology, Pathology +16

The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis

D L Boyle, K. Soma, J Hodge et al. · Annals of the Rheumatic Diseases · 2014 · 298 citations · Full text

Medicine, Pathobiology, Pharmacology +17

Regional analysis of <i>p53</i> mutations in rheumatoid arthritis synovium

Yuji Yamanishi, David L. Boyle, Sanna Rosengren et al. · Proceedings of the National Academy of Sciences · 2002 · 213 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Assessment of rituximab's immunomodulatory synovial effects (ARISE trial). 1: clinical and synovial biomarker results

Arthur Kavanaugh, Sanna Rosengren, Sang Jin Lee et al. · Annals of the Rheumatic Diseases · 2007 · 179 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

The JAK inhibitor CP-690,550 (tofacitinib) inhibits TNF-induced chemokine expression in fibroblast-like synoviocytes: autocrine role of type I interferon

Sanna Rosengren, Maripat Corr, Gary S. Firestein et al. · Annals of the Rheumatic Diseases · 2011 · 164 citations

Medicine, Immunology, Molecular Biology +17